Narin Apisarnthanarax

Phase II Evaluation of Gemcitabine Monotherapy for Cutaneous T-Cell Lymphoma

Madeleine Duvic, Rakhshandra Talpur, Sijin Wen et al. · Clinical Lymphoma & Myeloma · 2006 · 149 citations

Lymphoid Neoplasia, Phase Ii Evaluation, Medicine +5

Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results

Narin Apisarnthanarax, Michèle L. Donato, M Körbling et al. · Bone Marrow Transplantation · 2003 · 132 citations

Transplantation, Marrow Transplantation, Extracorporeal Photopheresis Therapy +5

CD25 Expression Is Correlated with Histological Grade and Response to Denileukin Diftitox in Cutaneous T-Cell Lymphoma

Rakhshandra Talpur, Daniel M. Jones, Alvaro J. Alencar et al. · Journal of Investigative Dermatology · 2006 · 104 citations · Full text

Cutaneous T-cell Lymphoma, Lymphoid Neoplasia, Autoimmune Disease +10

Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma

Madeleine Duvic, Narin Apisarnthanarax, Deborah S. Cohen et al. · Journal of the American Academy of Dermatology · 2003 · 67 citations

Cutaneous T-cell Lymphoma, Lymphoid Neoplasia, Combined Modality Therapy +8

Tazarotene 0.1% gel for refractory mycosis fungoides lesions: an open-label pilot study

Narin Apisarnthanarax, Rakhshandra Talpur, Staci Ward et al. · Journal of the American Academy of Dermatology · 2004 · 65 citations

Open-label Pilot Study, Pathology, Clinical Dermatology +4